52 Week Low Stocks Based on Artificial Intelligence: Returns up to 29.55% in 1 Month

52 Week Low Stocks

The 52 Week Low Stocks Package is designed for investors and analysts who need predictions for stocks currently at their 52-week low price level, offering the best market opportunities based on algo-trading. It includes 20 stocks with bullish and bearish signals and indicates the best stocks to invest in:

  • 52 Weeks Low Top 10 stocks for the long position
  • 52 Weeks Low Top 10 stocks for the short position

52 Week Low Stocks
Package Name: 52 Week Low Stocks
Recommended Positions: Long
Forecast Length: 1 Month (12/28/2018 – 01/28/2019)
I Know First Average: 15.95%
52 Week Low Stocks

10 out of 10 stock prices in this forecast for the 52 Week Low Stocks Package moved as predicted by the algorithm. BLUE was our best stock pick this week a return of 29.55%. DAN and PDFS followed with returns of 28.82% and 16.33% for the 1 Month period. The package saw an overall yield of 15.95% versus the S&P 500’s return of 6.23% implying a market premium of 9.72%.

bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company’s clinical programs in severe genetic diseases include its LentiGlobin product candidate to treat transfusion-dependent b-thalassemia (TDT) and to treat severe sickle cell disease (SCD) and its Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD). Its programs in oncology are built upon its lentiviral gene delivery and T cell engineering, with a focus on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. bb2121, its lead product candidate in oncology, is a CAR T cell product candidate for the treatment of multiple myeloma. It also has discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.